Kurgan Joins the Import Substitution Program
A Velpharm finished pharmaceutical forms manufacturing site has been opened in Kurgan. Most (37) of the 60 drugs from the company portfolio are import substituted drugs. They are used for treatment of endocrine disorders (diabetes mellitus), gastro-intestinal tract disorders, cardiovascular system disorders, neurological dermatological disorders, allergy. All of them are manufactured in full compliance with GMP standards.
Manufacture of the above-mentioned drugs has been initiated by Velpharm, a borrowing entity of the Industry Development Fund (IDF) in the South Urals.
Part of products of the new company will be supplied not only to the Russian regions, but also will be exported to Belarus, Kazakhstan, Vietnam, Mongolia, Moldova, Georgia, Armenia, Azerbaijan, Kyrgyzstan, Uzbekistan, Tajikistan, Afganistan.